AIRLINK 189.64 Decreased By ▼ -7.01 (-3.56%)
BOP 10.09 Decreased By ▼ -0.05 (-0.49%)
CNERGY 6.68 Decreased By ▼ -0.01 (-0.15%)
FCCL 34.14 Increased By ▲ 1.12 (3.39%)
FFL 17.09 Increased By ▲ 0.44 (2.64%)
FLYNG 23.83 Increased By ▲ 1.38 (6.15%)
HUBC 126.05 Decreased By ▼ -1.24 (-0.97%)
HUMNL 13.79 Decreased By ▼ -0.11 (-0.79%)
KEL 4.77 Increased By ▲ 0.01 (0.21%)
KOSM 6.58 Increased By ▲ 0.21 (3.3%)
MLCF 43.28 Increased By ▲ 1.06 (2.51%)
OGDC 224.96 Increased By ▲ 11.93 (5.6%)
PACE 7.38 Increased By ▲ 0.37 (5.28%)
PAEL 41.74 Increased By ▲ 0.87 (2.13%)
PIAHCLA 17.19 Increased By ▲ 0.37 (2.2%)
PIBTL 8.41 Increased By ▲ 0.12 (1.45%)
POWER 9.05 Increased By ▲ 0.23 (2.61%)
PPL 193.09 Increased By ▲ 9.52 (5.19%)
PRL 37.34 Decreased By ▼ -0.93 (-2.43%)
PTC 24.02 Decreased By ▼ -0.05 (-0.21%)
SEARL 94.54 Decreased By ▼ -0.57 (-0.6%)
SILK 0.99 Decreased By ▼ -0.01 (-1%)
SSGC 39.93 Decreased By ▼ -0.38 (-0.94%)
SYM 17.77 Decreased By ▼ -0.44 (-2.42%)
TELE 8.66 Decreased By ▼ -0.07 (-0.8%)
TPLP 12.39 Increased By ▲ 0.18 (1.47%)
TRG 62.65 Decreased By ▼ -1.71 (-2.66%)
WAVESAPP 10.28 Decreased By ▼ -0.16 (-1.53%)
WTL 1.75 Decreased By ▼ -0.04 (-2.23%)
YOUW 3.97 Decreased By ▼ -0.03 (-0.75%)
BR100 11,814 Increased By 90.4 (0.77%)
BR30 36,234 Increased By 874.6 (2.47%)
KSE100 113,247 Increased By 609 (0.54%)
KSE30 35,712 Increased By 253.6 (0.72%)

Asthma patients could lead a normal life, completely free from symptoms of the disease, and 'well-controlled and total controlled asthma' is maintainable after it is achieved.
The results of a year-long international study - GOAL (Gaining Optimal Asthma Control) challenge the way patients currently approach or manage asthma, says Professor Eric D. Bateman, professor of respiratory medicine at the University of Cape Town, South Africa.
Delivering his lecture on "aiming for total control in asthma management" at a symposium "From Goal to Asthma Control" at a local hotel here on Saturday, he said that attention must be drawn towards the need for better asthma management on part of doctors and patients alike.
Eric Bateman, who is also one of the leading investigators of the Goal study, maintained that the Goal findings are of paramount importance and serve as a major breakthrough in asthma management. The study establishes the efficacy of a new combination therapy for asthma and illustrates that the globally recognised treatment guidelines for asthma control are 100-percent achievable and a vast majority of asthma patients, currently living with the burden of the disease, can live an almost asthma-free life. The way asthma patients currently treat their disease fall far short of the standard definition of control as defined by the Goal study or the international guidelines for asthma control, he pointed out.

Copyright Business Recorder, 2006

Comments

Comments are closed.